+
in $
-0.81%
Fox Corporation
in $
-37.24%
Cano Health, Inc.
FOXA CANO-WT
Price 49.23 0.01
Movement -$ 0.40 -$ 0.01
Market Cap. 21.9 B 19.3 M
Volume 2.5 M 32,459
Volume μ 3.4 M 0
EPS TTM 4.09 0.00
P/E TTM 12.04 0.00
Dividend Yield TTM 1% -%
Shares Outstanding 444 M 2,121 M
Earnings Call Feb. 5, 2025 March 31, 2023

Financial Comparison

Financial Statements
Click to show
FOXA
CANO-WT
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
Profitability
Industry Average
Profit Margin
-3.73% YoY
-0.12
0.09
0.08
Gross Margin
+0.34% YoY
0.36
0.32
0.32
Operating Margin
-6.71% YoY
-0.10
0.15
0.14
EBT Margin
-4.12% YoY
-0.11
0.12
0.12
ETR
-% YoY
-
-
EPS
+8.97% YoY
-3.30
2.13
2.34
EPS Dil.
+9.44% YoY
-3.33
2.11
2.33
ROA
+4.23% YoY
-0.06
0.05
0.06
ROE
+10.97% YoY
-0.35
0.11
0.12
ROIC
+4.84% YoY
-0.09
0.08
0.08
Takeaways
  • Positive 5Y revenue growth of +72.15% and +35.46% for the past 10 Years
  • The profit margin of 0.08 implies a positive signal, comparing the net margin against the industry avg. of -0.12
Market Prospects
P/E
-4.06% YoY
0.24
15.11
14.52
P/B
+7.37% YoY
94.26
1.61
1.73
P/TB
+7.37% YoY
94.26
1.61
1.73
Earnings Yield
+3.90% YoY
0.01
0.07
0.07
Other Metrics
EBITDA[in mil.]
+1.94% YoY
-
2,428
2,476
EBITDA Margin
-4.70% YoY
0.05
0.17
0.17
WA[in mil.]
-6.99% YoY
-
566
529
WA Dil.[in mil.]
-6.99% YoY
-
566
529
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings FOXA
Earnings Call Nov. 4, 2024
Avg. EPS Forecast 1.11
Potential Delta 3 %
Avg. Revenue Forecast 3,373 Mil.
Potential Delta - %
Dividends
Company Average
Fox Corporation
$0.25
Industry Average
Entertainment
$0.36

Investor Relations

Index
FOXA
Annual Statement Aug. 11, 2023, midnight
Quarterly Statement Nov. 4, 2024, midnight
Earnings Call May 8, 2024, 11:50 a.m.
Next Earnings Call Feb. 5, 2025
Shareholder Meeting n/a
FDA Filing n/a
CANO-WT
Annual Statement March 15, 2023, midnight
Quarterly Statement Nov. 13, 2023, midnight
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a

Strategic Comparison

Risks & Opportunities

Yet not available for any. Try a different selection.